Shanghai Bio-heart Biological Technology Co., Ltd.
3 clinical trials · Sponsor
◉ Watch Shanghai Bio-heart Biological Technology Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Registry Trial of The Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System (NCT04179045) | Shanghai Bio-heart Biological Technology Co., Ltd. | 2021-03-01 |
| Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System Clinical Study (NCT03284255) | Shanghai Bio-heart Biological Technology Co., Ltd. | 2017-09-11 |
| Galaxy Rapamycin Drug-Eluting Bioresorbable Coronary Stent System First-in-man Study (NCT02844270) | Shanghai Bio-heart Biological Technology Co., Ltd. | 2016-08-09 |
Track Shanghai Bio-heart Biological Technology Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.